Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Metastatic malignant struma ovarii. Two case reports.

R D Thomas1, V B Batty

  • 1Department of Radiology, Southampton General Hospital, England.

Clinical Nuclear Medicine
|July 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stability and Cooling of the C_{7}^{2-} Dianion.

Physical review letters·2023
Same author

A field ionizer for photodetachment studies of negative ions.

The Review of scientific instruments·2022
Same author

Time-Resolved Photoelectron Studies of Thiophene and 2,5-Dimethylthiophene.

The journal of physical chemistry. A·2018
Same author

The ring-opening channel and the influence of Rydberg states on the excited state dynamics of furan and its derivatives.

The Journal of chemical physics·2018
Same author

Erratum: Rotationally Cold OH^{-} Ions in the Cryogenic Electrostatic Ion-Beam Storage Ring DESIREE [Phys. Rev. Lett. 119, 073001 (2017)].

Physical review letters·2018
Same author

Rotationally Cold OH^{-} Ions in the Cryogenic Electrostatic Ion-Beam Storage Ring DESIREE.

Physical review letters·2017

Malignant struma ovarii, a rare ovarian tumor, presents diagnostic and treatment challenges. While I-131 shows therapeutic potential, biochemical testing is more reliable for monitoring this rare cancer.

Area of Science:

  • Gynecologic Oncology
  • Endocrinology
  • Nuclear Medicine

Background:

  • Struma ovarii is a rare germ cell tumor predominantly composed of thyroid tissue.
  • Malignant transformation occurs in 5% of cases, with metastasis in only 5% of those.
  • The rarity of this condition complicates standardized treatment and imaging protocols.

Observation:

  • The authors present two cases of struma ovarii, detailing the complexities in their management.
  • Imaging and monitoring presented significant challenges in both cases.
  • Difficulties in diagnosis and follow-up underscore the need for refined management strategies.

Findings:

  • Radioactive iodine (I-131) demonstrates utility in both therapeutic applications and patient monitoring for struma ovarii.

Related Experiment Videos

  • Biochemical testing emerged as a more dependable marker for assessing disease status compared to imaging.
  • Effective management requires a multimodal approach integrating various diagnostic and therapeutic modalities.

    • Implications:

    • This study highlights the critical role of I-131 in managing malignant struma ovarii.
    • It emphasizes the superiority of biochemical markers over imaging for disease surveillance.
    • Further research into standardized protocols for this rare ovarian neoplasm is warranted to improve patient outcomes.